Home › Asset managers › Dimensional › 2024-2025 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Dimensional voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
6,073 proposals. The board-sponsored half of this list keeps the 6,000 proposals with the most funds behind them; the rest are in the interactive database. Every shareholder proposal it backed is listed in full.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Dimensional voted | Funds |
|---|---|---|---|---|---|---|---|
| PARKEN Sport & Entertainment A/S | April 23, 2025 | Authorize Share Repurchase Program | Capital Structure | Board | AGAINST | 7 | |
| PARKEN Sport & Entertainment A/S | April 23, 2025 | Reelect Erik Jensen Skjaerbaek as Director | Director Elections | Board | ABSTAIN | 7 | |
| PARKEN Sport & Entertainment A/S | April 23, 2025 | Reelect Henrik Mogelmose (Chair) as Director | Director Elections | Board | ABSTAIN | 7 | |
| PARKEN Sport & Entertainment A/S | April 23, 2025 | Reelect Michael Stenskrog (Vice Chair) as Director | Director Elections | Board | ABSTAIN | 7 | |
| PCI Technology Group Co., Ltd. | May 8, 2025 | Approve Credit Line Application and Provision of Guarantee | Capital Structure | Board | AGAINST | 7 | |
| Patterson-UTI Energy, Inc. | June 5, 2025 | Approval, on an advisory basis, of Patterson-UTI's compensation of its named executive officers. | Say-on-Pay | Board | AGAINST | 7 | |
| PayPoint Plc | August 1, 2024 | Approve Remuneration Policy | Compensation | Board | AGAINST | 7 | |
| Paysign, Inc. | May 7, 2025 | Election of Directors: Jeffrey B. Newman | Director Elections | Board | WITHHOLD | 7 | |
| Per Aarsleff Holding A/S | January 30, 2025 | Approve Remuneration Report | Compensation | Board | AGAINST | 7 | |
| Photocure ASA | May 5, 2025 | Approve Equity Plan Financing | Compensation | Board | AGAINST | 7 | |
| Photocure ASA | May 5, 2025 | Approve Issuance of up to 15 Percent of Share Capital without Preemptive Rights (Third Proposal) | Capital Structure | Board | AGAINST | 7 | |
| Photocure ASA | May 5, 2025 | Approve Issuance of up to 20 Percent of Share Capital without Preemptive Rights (Second Proposal) | Capital Structure | Board | AGAINST | 7 | |
| Photocure ASA | May 5, 2025 | Approve Issuance of up to 25 Percent of Share Capital without Preemptive Rights (First Proposal) | Capital Structure | Board | AGAINST | 7 | |
| Photocure ASA | May 5, 2025 | Approve Remuneration Policy And Other Terms of Employment For Executive Management | Compensation | Board | AGAINST | 7 | |
| Photocure ASA | May 5, 2025 | Approve Remuneration Statement | Compensation | Board | AGAINST | 7 | |
| Photocure ASA | May 5, 2025 | Approve Remuneration of Directors in the Amount of NOK 620,000 for Chairman and NOK 360,000 for Other Directors | Compensation | Board | AGAINST | 7 | |
| Pico Far East Holdings Limited | March 21, 2025 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 7 | |
| Pico Far East Holdings Limited | March 21, 2025 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 7 | |
| Planet Labs PBC | July 11, 2024 | To approve, on a non-binding advisory basis, the compensation of our named executive officers ("Say-on-Pay Vote"). | Say-on-Pay | Board | AGAINST | 7 | |
| Planet Labs PBC | July 11, 2024 | To elect the following individuals to serve on the board of directors of Planet Labs PBC as Class III directors, until the 2027 annual meeting of stockholders and until their respective successors shall have been duly elected and qualified: Kristen Robinson | Director Elections | Board | WITHHOLD | 7 | |
| Platinum Asset Management Limited | November 12, 2024 | Approve Remuneration Report | Compensation | Board | AGAINST | 7 | |
| Platinum Asset Management Limited | November 12, 2024 | Approve the Spill Resolution | Compensation | Board | AGAINST | 7 | |
| Pollard Banknote Limited | May 8, 2025 | Elect Director Douglas Pollard | Director Elections | Board | AGAINST | 7 | |
| Pollard Banknote Limited | May 8, 2025 | Elect Director Gordon Pollard | Director Elections | Board | AGAINST | 7 | |
| Pollard Banknote Limited | May 8, 2025 | Elect Director John Pollard | Director Elections | Board | AGAINST | 7 | |
| Postal Savings Bank of China Co., Ltd. | October 25, 2024 | Elect Chen Binghua as Director | Director Elections | Board | AGAINST | 7 | |
| Postal Savings Bank of China Co., Ltd. | October 25, 2024 | Elect Liu Ruigang as Director | Director Elections | Board | AGAINST | 7 | |
| Pulmonx Corporation | May 22, 2025 | Election of Directors: Daniel P. Florin | Director Elections | Board | WITHHOLD | 7 | |
| Pulmonx Corporation | May 22, 2025 | Election of Directors: Richard M. Ferrari | Director Elections | Board | WITHHOLD | 7 | |
| Pulmonx Corporation | May 22, 2025 | Election of Directors: Steve Williamson | Director Elections | Board | WITHHOLD | 7 | |
| Pulmonx Corporation | May 22, 2025 | To conduct a non-binding advisory vote to approve our executive compensation. | Say-on-Pay | Board | AGAINST | 7 | |
| Qingdao East Steel Tower Stock Co., Ltd. | May 21, 2025 | Approve Provision of Guarantee | Capital Structure | Board | AGAINST | 7 | |
| Qingdao East Steel Tower Stock Co., Ltd. | May 21, 2025 | Approve Use of Idle Own Funds for Entrusted Asset Management | Extraordinary Transactions | Board | AGAINST | 7 | |
| Qingdao Gaoce Technology Co., Ltd. | April 7, 2025 | Approve Credit Line Application and Estimated Amount of Guarantee | Capital Structure | Board | AGAINST | 7 | |
| Relay Therapeutics, Inc. | June 6, 2025 | To consider and act upon an advisory vote on the compensation of our named executive officers; | Say-on-Pay | Board | AGAINST | 7 | |
| Relay Therapeutics, Inc. | June 6, 2025 | To elect the two class II directors to our board of directors, to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Alexis Borisy | Director Elections | Board | WITHHOLD | 7 | |
| Rex International Holding Limited | April 25, 2025 | Approve Issuance of Equity or Equity-Linked Securities with or without Preemptive Rights | Capital Structure | Board | AGAINST | 7 | |
| Rex International Holding Limited | April 25, 2025 | Approve Issuance of Shares Under the Rex International Employee Share Option Scheme | Compensation | Board | AGAINST | 7 | |
| Rex International Holding Limited | April 25, 2025 | Approve Issuance of Shares Under the Rex International Performance Share Plan | Compensation | Board | AGAINST | 7 | |
| Rex International Holding Limited | April 25, 2025 | Elect Heng Su-Ling Mae as Director | Director Elections | Board | AGAINST | 7 | |
| Rianlon Corp. | May 16, 2025 | Approve Application of Credit Line and Provision of Guarantee | Capital Structure | Board | AGAINST | 7 | |
| Rianlon Corp. | May 16, 2025 | Approve Financial Assistance Provision | Capital Structure | Board | AGAINST | 7 | |
| Rianlon Corp. | May 16, 2025 | Approve Use of Fund for Cash Management | Extraordinary Transactions | Board | AGAINST | 7 | |
| Rigel Pharmaceuticals, Inc. | May 22, 2025 | To approve an amendment to our 2018 Equity Incentive Plan, as amended (the "Amended 2018 Plan"), to add an additional 700,000 shares to the number of shares of common stock authorized for issuance under the Amended 2018 Plan. | Compensation | Board | AGAINST | 7 | |
| Royalty Pharma Plc | May 12, 2025 | A non-binding advisory vote to approve executive compensation. | Say-on-Pay | Board | AGAINST | 7 | |
| Royalty Pharma Plc | May 12, 2025 | Approve on a binding basis our U.K. directors' remuneration policy. | Compensation | Board | AGAINST | 7 | |
| Royalty Pharma Plc | May 12, 2025 | Approve on a non-binding advisory basis our U.K. directors' remuneration report (other than the part containing the directors' remuneration policy) for the fiscal year ended December 31, 2024. | Compensation | Board | AGAINST | 7 | |
| Royalty Pharma Plc | May 12, 2025 | Election of Directors: Bonnie Bassler, Ph.D. | Director Elections | Board | AGAINST | 7 | |
| Royalty Pharma Plc | May 12, 2025 | Election of Directors: David Hodgson | Director Elections | Board | AGAINST | 7 | |
| Royalty Pharma Plc | May 12, 2025 | Election of Directors: Errol De Souza, Ph.D. | Director Elections | Board | AGAINST | 7 | |
| Royalty Pharma Plc | May 12, 2025 | Election of Directors: Gregory Norden | Director Elections | Board | AGAINST | 7 | |
| Runjian Co., Ltd. | February 7, 2025 | Approve Authorization of Board to Handle All Related Matters | Compensation | Board | AGAINST | 7 | |
| Runjian Co., Ltd. | February 7, 2025 | Approve Draft and Summary of Stock Option and Performance Share Incentive Plan | Compensation | Board | AGAINST | 7 | |
| Runjian Co., Ltd. | February 7, 2025 | Approve the Implementation Assessment and Management Measures for the Stock Option and Performance Share Incentive Plan | Compensation | Board | AGAINST | 7 | |
| SEI Investments Company | May 28, 2025 | Election of Directors: Jonathan A. Brassington | Director Elections | Board | AGAINST | 7 | |
| SEI Investments Company | May 28, 2025 | To approve, on an advisory basis, the compensation of named executive officers. | Say-on-Pay | Board | AGAINST | 7 | |
| SINOPEC Engineering (Group) Co., Ltd. | May 9, 2025 | Approve Cap for the Amount of Parent Guarantee | Capital Structure | Board | AGAINST | 7 | |
| Sansure Biotech, Inc. | March 27, 2025 | Approve Acquisition of Equity, Capital Injection and Co-investment with Related Party | Extraordinary Transactions | Board | AGAINST | 7 | |
| Sany Heavy Industry Co., Ltd. | January 21, 2025 | Approve Provision of Financial Aid | Capital Structure | Board | AGAINST | 7 | |
| Sany Heavy Industry Co., Ltd. | January 21, 2025 | Approve Provision of Guarantee to Subsidiary | Capital Structure | Board | AGAINST | 7 | |
| Sany Heavy Industry Co., Ltd. | April 21, 2025 | Approve Authorization of the Board to Handle All Matters Related to Employee Share Purchase Plan | Compensation | Board | AGAINST | 7 | |
| Sany Heavy Industry Co., Ltd. | April 21, 2025 | Approve Draft and Summary of Employee Share Purchase Plan | Compensation | Board | AGAINST | 7 | |
| Sany Heavy Industry Co., Ltd. | April 21, 2025 | Approve Management Method of Employee Share Purchase Plan | Compensation | Board | AGAINST | 7 | |
| Sany Heavy Industry Co., Ltd. | May 9, 2025 | Approve Application of Bank Credit Lines | Capital Structure | Board | AGAINST | 7 | |
| Sany Heavy Industry Co., Ltd. | May 9, 2025 | Approve Use of Idle Own Funds for Investment in Financial Products | Extraordinary Transactions | Board | AGAINST | 7 | |
| Sartorius Stedim Biotech SA | March 25, 2025 | Approve Compensation Report of Corporate Officers | Compensation | Board | AGAINST | 7 | |
| Sartorius Stedim Biotech SA | March 25, 2025 | Approve Issuance of Equity or Equity-Linked Securities Reserved for Qualified Investors, up to Aggregate Nominal Amount of EUR 6 Million | Capital Structure | Board | AGAINST | 7 | |
| Sartorius Stedim Biotech SA | March 25, 2025 | Approve Remuneration Policy of CEO | Compensation | Board | AGAINST | 7 | |
| Sartorius Stedim Biotech SA | March 25, 2025 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above | Capital Structure | Board | AGAINST | 7 | |
| Sartorius Stedim Biotech SA | March 25, 2025 | Authorize Capital Increase of up to 20 Percent of Issued Capital for Contributions in Kind | Capital Structure | Board | AGAINST | 7 | |
| Sartorius Stedim Biotech SA | March 25, 2025 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans | Compensation | Board | AGAINST | 7 | |
| Sartorius Stedim Biotech SA | March 25, 2025 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights (Rights Issue) up to Aggregate Nominal Amount of EUR 6 Million | Capital Structure | Board | AGAINST | 7 | |
| Sartorius Stedim Biotech SA | March 25, 2025 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 6 Million | Capital Structure | Board | AGAINST | 7 | |
| Sartorius Stedim Biotech SA | March 25, 2025 | Authorize Repurchase of Up to 0.10 Percent of Issued Share Capital | Capital Structure | Board | AGAINST | 7 | |
| Sartorius Stedim Biotech SA | March 25, 2025 | Authorize up to 10 Percent of Issued Capital for Use in Restricted Stock Plans | Compensation | Board | AGAINST | 7 | |
| Sartorius Stedim Biotech SA | March 25, 2025 | Reelect Joachim Kreuzburg as Director | Director Elections | Board | AGAINST | 7 | |
| Sartorius Stedim Biotech SA | March 25, 2025 | Reelect Lothar Kappich as Director | Director Elections | Board | AGAINST | 7 | |
| Sartorius Stedim Biotech SA | March 25, 2025 | Reelect Pascale Boissel as Director | Director Elections | Board | AGAINST | 7 | |
| Saudi Industrial Investment Group | May 21, 2025 | Approve Employees Stock Incentive Program and Authorize Board to Ratify any Future Amendments on the Program | Compensation | Board | AGAINST | 7 | |
| Saudi Industrial Investment Group | May 21, 2025 | Authorize Share Repurchase Program Up to 1,000,000 Shares to be Allocated for the Long-term Employee Incentive Program and Authorize Board to Complete the Purchase within a Maximum of 12 Months Period from Date of General Assembly | Capital Structure | Board | AGAINST | 7 | |
| Seven West Media Limited | November 7, 2024 | Approve Grant of Performance Rights to Jeffrey Howard | Compensation | Board | AGAINST | 7 | |
| Seven West Media Limited | November 7, 2024 | Approve Remuneration Report | Compensation | Board | AGAINST | 7 | |
| Shandong Hualu-Hengsheng Chemical Co., Ltd. | April 29, 2025 | Approve Use of Own Funds for Structured Deposits | Extraordinary Transactions | Board | AGAINST | 7 | |
| Shandong Humon Smelting Co. Ltd. | April 18, 2025 | Approve Application of Comprehensive Credit Line | Capital Structure | Board | AGAINST | 7 | |
| Shandong Linglong Tyre Co., Ltd. | May 15, 2025 | Approve Credit Line Application and Guarantee Matters | Capital Structure | Board | AGAINST | 7 | |
| Shandong Publishing & Media Co., Ltd. | May 7, 2025 | Approve Use of Idle Own Funds for Cash Management | Extraordinary Transactions | Board | AGAINST | 7 | |
| Shandong Xiantan Co., Ltd. | May 12, 2025 | Approve Use of Idle Own Funds for Cash Management | Extraordinary Transactions | Board | AGAINST | 7 | |
| Shandong Xiantan Co., Ltd. | May 12, 2025 | Approve Use of Idle Own Funds for Securities Investment | Extraordinary Transactions | Board | AGAINST | 7 | |
| Shanghai Environment Group Co., Ltd. | April 24, 2025 | Approve Application of Credit Lines | Capital Structure | Board | AGAINST | 7 | |
| Shanghai Industrial Urban Development Group Limited | May 22, 2025 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 7 | |
| Shanghai Industrial Urban Development Group Limited | May 22, 2025 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 7 | |
| Shanghai Industrial Urban Development Group Limited | May 22, 2025 | Elect Fan Ren Da, Anthony as Director | Director Elections | Board | AGAINST | 7 | |
| Shanghai Jin Jiang International Hotels Co., Ltd. | September 20, 2024 | Approve Authorization of the Board to Handle All Related Matters | Compensation | Board | AGAINST | 7 | |
| Shanghai Jin Jiang International Hotels Co., Ltd. | September 20, 2024 | Approve Draft and Summary of Performance Shares Incentive Plan | Compensation | Board | AGAINST | 7 | |
| Shanghai Jin Jiang International Hotels Co., Ltd. | September 20, 2024 | Approve Methods to Assess the Performance of Plan Participants | Compensation | Board | AGAINST | 7 | |
| Shanghai Putailai New Energy Technology Co., Ltd. | January 6, 2025 | Approve Provision of Guarantees | Capital Structure | Board | AGAINST | 7 | |
| Shanghai Putailai New Energy Technology Co., Ltd. | April 10, 2025 | Approve Authorization of the Board to Handle All Related Matters | Compensation | Board | AGAINST | 7 | |
| Shanghai Putailai New Energy Technology Co., Ltd. | April 10, 2025 | Approve Draft and Summary of Stock Option Incentive Plan | Compensation | Board | AGAINST | 7 | |
| Shanghai Putailai New Energy Technology Co., Ltd. | April 10, 2025 | Approve Methods to Assess the Performance of Plan Participants | Compensation | Board | AGAINST | 7 | |
| Shanghai Putailai New Energy Technology Co., Ltd. | May 16, 2025 | Amend Management System for Company's Shareholdings by Directors, Senior Management and Their Changes | Compensation | Board | AGAINST | 7 |
← Previous Page 44 of 61 Next →
← Back to Dimensional 2024-2025 overview
Built November 1, 2026 from SEC Form N-PX filings.